ArticleArthritis research & therapy2022

Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study.

Christophe Schmitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.